Concepts for banking tissue in urologic oncology-the international bladder cancer bankGOEBELL, Peter J; GROSHEN, Susan; COTE, Richard J et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 413-415, issn 1078-0432, 3 p., 1Article

Diagnosis of bladder cancer by analysis of urinary fibronectinMENENDEZ, Violeta; FERNANDEZ-SUAREZ, Antonio; GALAN, Juan Antonio et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 2, pp 284-289, issn 0090-4295, 6 p.Article

Down-regulation of S100C is associated with bladder cancer progression and poor survivalASHFAQUE AHMED MEMON; SORENSEN, Boe Sandahl; MELDGAARD, Peter et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 606-611, issn 1078-0432, 6 p., 1Article

Does warfarin therapy influence the risk of bladder cancer?BLUMENTALS, William A; FOULIS, Philip R; SCHWARTZ, Skai W et al.Thrombosis and haemostasis. 2004, Vol 91, Num 4, pp 801-805, issn 0340-6245, 5 p.Article

Proteomics and genomics of urinary bladder cancerMOHAMMED, Sulma I; RAHMAN, Munazzah.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 9, pp 1194-1207, issn 1862-8346, 14 p.Article

A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer riskTINGJIA LAO; WEIGUO GU; QINGSHAN HUANG et al.Mutagenesis. 2008, Vol 23, Num 6, pp 523-532, issn 0267-8357, 10 p.Article

Genotypes of TNF-α, VECF, hOGG1, GSTM1, and GSTT1: Useful determinants for clinical outcome of bladder cancerKIM, Eun-Jung; JEONG, Pildu; QUAN, Changyi et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 1, pp 70-75, issn 0090-4295, 6 p.Article

Cancer de la vessieBAUER, J.Médecine et hygiène. 2004, Vol 62, Num 2482, pp 1049-1051, issn 0025-6749, 3 p.Article

Detection of bladder cancer using a point-of-care proteomic assayGROSSMAN, H. Barton; MESSING, Edward; SOLOWAY, Mark et al.JAMA, the journal of the American Medical Association. 2005, Vol 293, Num 7, pp 810-816, issn 0098-7484, 7 p.Article

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-upBELLMUNT, J; ORSOLA, A; LEOW, J. J et al.Annals of oncology. 2014, Vol 25, issn 0923-7534, iii40-iii48, SUP3Article

Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder CancerGARCIA-CLOSAS, Montserrat; ROTHMAN, Nathaniel; PURDUE, Mark P et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 7, pp 2211-2220, issn 0008-5472, 10 p.Article

Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarkerMORGAN, Richard; BRYAN, Richard T; KNOWLES, Margaret A et al.European journal of cancer (1990). 2013, Vol 49, Num 9, pp 2214-2222, issn 0959-8049, 9 p.Article

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancerBOMAN, K; LARSSON, A. H; SEGERSTEN, U et al.British journal of cancer. 2013, Vol 108, Num 11, pp 2321-2328, issn 0007-0920, 8 p.Article

Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer CellsREDELMAN-SIDI, Gil; LYER, Gopa; SOLIT, David B et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1156-1167, issn 0008-5472, 12 p.Article

Understanding Avoidance, Refusal, and Abandonment of Chemotherapy Before and After Cystectomy for Bladder CancerREHMAN, Shabnam; CRANE, Alice; GURU, Khurshid A et al.Urology (Ridgewood, NJ). 2013, Vol 82, Num 6, pp 1370-1375, issn 0090-4295, 6 p.Article

Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancerMIZUTANI, Yoichi; KATSUOKA, Yoji; BONAVIDA, Benjamin et al.International journal of oncology. 2012, Vol 40, Num 4, pp 1246-1250, issn 1019-6439, 5 p.Article

Smoking and Survival After Radical Cystectomy for Bladder CancerLEE, Chunwoo; KWANG HYUN KIM; YOU, Dalsan et al.Urology (Ridgewood, NJ). 2012, Vol 80, Num 6, pp 1307-1312, issn 0090-4295, 6 p.Article

Impact of a Bladder Cancer Diagnosis on Smoking BehaviorBASSETT, Jeffrey C; GORE, John L; CHI, Amanda C et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1871-1878, issn 0732-183X, 8 p.Conference Paper

Intravesical Interleukin-15 Gene Therapy in an Orthotopic Bladder Cancer ModelMATSUMOTO, Kazuhiro; KIKUCHI, Eiji; HORINAGA, Minoru et al.Human gene therapy. 2011, Vol 22, Num 11, pp 1423-1432, issn 1043-0342, 10 p.Article

AdCD40L Immunogene Therapy for Bladder Carcinoma— The First Phase I/IIa TrialMALMSTRÖM, Per-Uno; LOSKOG, Angelica S. I; LINDQVIST, Camilla A et al.Clinical cancer research (Print). 2010, Vol 16, Num 12, pp 3279-3287, issn 1078-0432, 9 p.Article

Use of Radical Cystectomy for Patients With Invasive Bladder CancerGORE, John L; LITWIN, Mark S; JULIE LAI et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 11, pp 802-811, issn 0027-8874, 10 p.Article

Hypertension, diuretics and antihypertensives in relation to bladder cancerXUEJUAN JIANG; CASTELAO, J. Esteban; YUAN, Jian-Min et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 11, pp 1964-1971, issn 0143-3334, 8 p.Article

Serum Vitamin D and Risk of Bladder CancerMONDUL, Alison M; WEINSTEIN, Stephanie J; MÄNNISTÖ, Satu et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9218-9223, issn 0008-5472, 6 p.Article

New concepts of biobanks—strategic chance for uro-oncologyGOEBELL, Peter J; MORENTE, Manuel M.Urologic oncology. 2010, Vol 28, Num 4, pp 449-457, issn 1078-1439, 9 p.Conference Paper

Bladder Cancer-Associated Gene Expression Signatures Identified by Profiling of Exfoliated UrotheliaROSSER, Charles J; LI LIU; YIJUN SUN et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 2, pp 444-453, issn 1055-9965, 10 p.Article